Stocks

Vericel VCEL

Health care sectorNasdaq

What to see in Vericel now

Is Wall Street adding or cutting?+40

319 13F filers hold it · +40 against the quarter before · shares held +0.2%

Holdings of 06/30
Who bought more than 5%?2.8%

Soleus Capital Master Fund holds 2.8% · −2.2pp on the report before

Filed 08/13
What comes next?10/08 (Thu)

10/08 estimated earnings

Due 10/08

Company

Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Headquarters
Burlington, Massachusetts
Fiscal year end
12/31
Next earnings
10/08, estimated
  • 319 13F filers hold it · +40 against the quarter before · shares held +0.2%Holdings of 06/30
  • Soleus Capital Master Fund holds 2.8% · −2.2pp on the report beforeFiled 08/13

Funds

13F filers: 319 · +40 since the quarter before · 06/30 holdings

Famous funds that held Vericel in their latest 13F report.

FundValueSince the quarter before
Mirae Asset Global ETFS HoldingsVericel VCEL · 06/30 holdings$1.2MNo quarter before
Mirae Asset Global InvestmentsVericel VCEL · 06/30 holdings$101.6KTrimmed −13.7%
All tracked funds

5% stakes

Holder
Soleus Capital Master Fund08/132.8%1,458,882 sh−2.2pp
Vanguard Capital Management04/305.11%2,603,128 shFirst report
Soleus Capital Master Fund04/015%2,549,079 shFirst report
Brown Capital Management25/11/123.87%1,950,989 sh−2.7pp
State Street25/11/105.6%2,807,242 shFirst report
All 5% stake reports on Vericel

26-week trading